Epigenetic control using natural products and synthetic molecules

被引:63
作者
Suzuki, T [1 ]
Miyata, N [1 ]
机构
[1] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan
关键词
epigenetics; DNA methylation; histone modification; inhibitor; activator; epigenetic therapy;
D O I
10.2174/092986706776361067
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The term '' epigenetics '' is defined as '' heritable changes in gene expression that occur without changes in DNA sequence ''. Recently, it has been revealed that DNA methylation and historic modifications such as acetylation. methylation and phosphorylation are epigenetic mechanisms according to this definition. In other words, these posttranslational modifications are important factors in determining when and where a gene will be expressed. To date, several enzymes that catalyze DNA or historic modifications have been identified, such as DNA methyltransferases and histone deacetylases. Inhibitors and activators of enzymes controlling epigenetic modifications are considered useful not only as tools for the elucidation of cellular and biological phenomena, but also as therapeutic agents, since disruption of the balance of epigenetic networks is known to cause sonic disease states such as cancer. In this review, we present natural products and synthetic molecules that inhibit or activate enzymes catalyzing DNA methylation or historic modifications, and discuss the potential of epigenetic therapy.
引用
收藏
页码:935 / 958
页数:24
相关论文
共 246 条
[1]   Nucleosomal histone kinase-1 phosphorylates H2A Thr 119 during mitosis in the early Drosophila embryo [J].
Aihara, H ;
Nakagawa, T ;
Yasui, K ;
Ohta, T ;
Hirose, S ;
Dhomae, N ;
Takio, K ;
Kaneko, M ;
Takeshima, Y ;
Muramatsu, M ;
Ito, T .
GENES & DEVELOPMENT, 2004, 18 (08) :877-888
[2]   Alteration of cell cycle-dependent histone phosphorylations by okadaic acid - Induction of mitosis-specific H3 phosphorylation and chromatin condensation in mammalian interphase cells [J].
Ajiro, K ;
Yoda, K ;
Utsumi, K ;
Nishikawa, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :13197-13201
[3]   Mereaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors [J].
Anandan, SK ;
Ward, JS ;
Brokx, RD ;
Bray, MR ;
Patel, DV ;
Xiao, XX .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (08) :1969-1972
[4]   Histone deacetylase inhibitors: From chromatin remodeling to experimental cancer therapeutics [J].
Arts, J ;
de Schepper, S ;
Van Emelen, K .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (22) :2343-2350
[5]   Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824 [J].
Atadja, P ;
Gao, L ;
Kwon, P ;
Trogani, N ;
Walker, H ;
Hsu, M ;
Yeleswarapu, L ;
Chandramouli, N ;
Perez, L ;
Versace, R ;
Wu, A ;
Sambucetti, L ;
Lassota, P ;
Cohen, D ;
Bair, K ;
Wood, A ;
Remiszewski, S .
CANCER RESEARCH, 2004, 64 (02) :689-695
[6]   Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription [J].
Balasubramanyam, K ;
Varier, RA ;
Altaf, M ;
Swaminathan, V ;
Siddappa, NB ;
Ranga, U ;
Kundu, TK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (49) :51163-51171
[7]   Small molecule modulators of histone acetyltransferase p300 [J].
Balasubramanyam, K ;
Swaminathan, V ;
Ranganathan, A ;
Kundu, TK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (21) :19134-19140
[8]   The impact of chromatin in human cancer: linking DNA methylation to gene silencing [J].
Ballestar, E ;
Esteller, M .
CARCINOGENESIS, 2002, 23 (07) :1103-1109
[9]   Reversing histone methylation [J].
Bannister, AJ ;
Kouzarides, T .
NATURE, 2005, 436 (7054) :1103-1106
[10]   Methylation at arginine 17 of histone H3 is linked to gene activation [J].
Bauer, UM ;
Daujat, S ;
Nielsen, SJ ;
Nightingale, K ;
Kouzarides, T .
EMBO REPORTS, 2002, 3 (01) :39-44